INTRODUCTION
Vibrio parahaemolyticus is a Gram-negative food-and water-borne pathogen that is recognized worldwide as a causative agent of gastroenteritis associated with the consumption of undercooked seafood (22) . Gastrointestinal infection is characterized by acute self-limiting diarrhea, abdominal cramps, nausea, and vomiting. In approximately 5% of cases, V.
parahaemolyticus gastrointestinal infection can progress to septicemia and may be fatal for immune compromised patients including those with leukemia, liver disease and patients infected by human immunodeficiency virus AIDS (14, 28) .
The thermostable direct hemolysin (TDH) is a widely recognized virulence factor of V.
parahaemolyticus. This hemolysin is associated with the Kanagawa phenomenon, which is a beta-hemolysis reaction on a defined blood agar (11) . TDH is encoded by 1-2 genes (tdh-a and tdh-s) and the protein increases permeability in human erythrocytes (19), increases chloride secretion in the intestinal lumen (29), and is also thought to be responsible for enterotoxigenicity in a rabbit small intestine model (5, 23) . Early studies demonstrated that deletion of tdh-s and tdh-a will significantly reduce fluid accumulation in a rabbit ileal-loop model, but the phenotype is not completely abrogated suggesting that other virulence factors could be involved in pathogenicity (20, 26) .
In addition to TDH, V. parahaemolyticus encodes two distinct type III secretion systems (T3SSs) (21). T3SSs are used by Gram-negative pathogens to secrete and translocate effector proteins into the cytosol of eukaryotic cells (9, 16) . In vitro studies have shown that the T3SS1 (encoded on chromosome I) is required to induce cytotoxicity in several cell lines (13, 25, 33) .
This secretion system has been associated with several phenotypic changes including actin rearrangement, autophagy and oncosis (7, 33) . Moreover, it has been demonstrated that T3SS2 can induce cytotoxicity in Caco-2 cells and also plays an important role in fluid secretion based on in vivo models (18, 27).
Several animal challenge models have been used to study the pathogenesis of V.
parahaemolyticus including orogastric and peritoneal mouse infections (13, 15) , rabbit ileal-loop ligations (4, 5) , and oral infections in suckling rabbits and mice (8, 31) . Some of this work demonstrated that V. parahaemolyticus can cause lethality in mice via oral or intraperitoneal injection (13, 15) . These models have provided clues about the pathophysiology of V.
parahaemolyticus, but in most cases these models have not been used as comparative systems to study the distinct contributions of T3SS1 and T3SS2 to pathogenesis. In the case of other pathogens, newborn piglets have been used to study pathogenesis of Campylobacter jejuni and Escherichia coli infections; piglets offer and added advantage of having a higher degree of similarity with human physiology (2, 3, 30) . In the case of Pseudomonas aeruginosa, an intrapulmonary mouse model has been developed to assess the role of the T3SS during lung infection (1).
The aim of the present study was to develop robust animal models that will allow investigators to determine the contribution of V. parahaemolyticus effector proteins in the pathophysiology of gastroenteritis and/or lethality. The presence of gastrointestinal clinical sings was evaluated for infected piglets and we found that deletion of T3SS2 attenuated acute diarrhea.
A murine pulmonary model showed significant attenuation in mortality with deletion of a functional T3SS1. Findings from these two robust models support the assertion that the two V. parahaemolyticus contribute to distinct pathogenic mechanisms during infection.
MATERIAL AND METHODS
Bacterial strains. Wild-type V. parahaemolyticus NY-4 (serotype O3:K6) and deletion mutants ΔvcrD (T3SS1 KO), ΔescV (T3SS2 KO), and ΔvcrD/escV (T3SS1/2 KO) were generated previously (Table 1 ) (33) . Bacterial strains were grown 6-8 hr in Luria-Bertani (LB) media supplemented with 2.5% NaCl (LB-S) and shaking (250 rpm) at 37ºC. Strains were not induced to express T3SSs before use in animals. Deletion mutants ΔexsD and ΔexsA (Table 1) were included in our analysis of hemolytic activity. The former expresses the T3SS1 constitutively and the latter serves as an alternative knockout of the T3SS1. A tdh-a deletion mutant was generated using previously described methods (26), except we employed a modified set of oligonucleotide primers (Table 1) .
Comparison of growth rates. The growth rates of NY-4 (serotype O3:K6), T3SS1 KO, T3SS2 KO, and T3SS1/2 KO were compared using a Bioscreen C plate reader (Oy Growth Curves AB Ltd., Helsinki, Finland). Briefly, 20 µL of overnight culture was inoculated into 180 µL of fresh LB-S media and the OD 600 was monitored over 24 h. Growth curves were repeated three times with ten independent wells per replicate. After 24 h the bacterial count (colony forming units; CFU) was determined by drop-plate method (10) .
Hemolytic assay. The hemolytic activity of the supernatants was evaluated by first preparing 10 ml of overnight culture, centrifuging (4,000 xg for 10 min) at room temperature and transferring supernatant to 15 ml concentrators (Amicon Ultra-15, PLBC Ultracel-PL Membrane, 3 kDa).
Supernatant was concentrated to ~10% of original volume (~ 1 ml). Human erythrocytes (HRBCs; 2% suspension in Alsever solution from a single donor; Innovative Research, Novi, MI) were pelleted, washed four times and resuspended in an equal volume of PBS (pH 7.4) before being added to supernatant samples (1:1). The mixtures were incubated at 37ºC for 4 h after which samples were briefly centrifuged (600 xg for 3 min) and the hemolytic activity from Chemical CO, St. Louis, MO, USA) was added. Three biological replicates (including three technical replicates each) were used in the analysis and hemolytic activity of each strain was then normalized against the log concentration from the original culture (CFU/ml). Normalized values were expressed as a proportion of 100% lysis and compared using a one way ANOVA.
Piglet Model. Piglets were taken from the dam when they were approximately 6 h old and were raised until they were 48 h old. Piglets were fed three times a day with infant milk formula (Enfamil® Lipil Milk-Based Infant Formula with Iron) using individual feeders and with increasing volume from 80 ml to 120 ml until 5 days old. Piglets of both genders were used in equal frequency and the average body weight at infection was 1.4 kg (SD ± 0.15 kg).
Dose determination. For dose determination, 20 ml of 6 h old cultures of bacteria with an OD 600 of 2.5-2.7 were centrifuged at 4,000 xg for 10 min at room temperature and were resuspended in 10 ml sterile PBS (pH 7.4). Serial ten-fold dilutions were generated corresponding to 10 6 to 10 12 CFU/ml. Inoculum was mixed with 10 ml of infant milk formula and was placed in clean and disinfected feeders, allowing each pig to drink the complete dose. The feeders were refilled several times with a small amount of infant formula (5 ml) to assure that the bulk of the inoculum was ingested.
Experimental design. After dose determination trials, we performed three independent experiments consisting of two piglets per bacterial strain (treatment), for a total of 6 piglets per treatment. Treatments consisted of a dose of 10 11 CFU of either NY-4 (serotype O3:K6), T3SS1
KO, T3SS2 KO, or phosphate buffered saline (PBS, pH 7.4) as a vehicle control.
Clinical observations. Body temperature of each piglet was evaluated rectally and individual rectal swabs were taken and placed immediately in 10 ml sterile PBS prior to infection. All piglets were observed every 2 h post inoculation and clinical signs were evaluated (diarrhea, vomiting, feed consumption, and alertness). In addition, body temperature and rectal swabs were taken to assess pyrexia and bacterial shedding, respectively. The occurrence of diarrhea was evaluated by a subjective score; presence of soft to liquid feces in swab (+), presence of soft to liquid feces on the swab and stained perineum (++), and presence of soft to liquid feces on the swab, stained perineum and presence of large amount of loose fecal discharge in the cage (+++).
Vomiting was recorded as present or absent. After 8 h and 24 h post inoculation, one piglet from each group was euthanized with an intravenous overdose of 2 ml of pentobarbital. A full necropsy was performed immediately after death and gross changes were recorded. Samples for bacteriology (lung, liver, spleen, kidney, stomach, duodenum, jejunum, ileum, cecum, colon, and rectum) were immediately placed in 10 ml sterile PBS. Samples for histological analysis were placed in 10% formaldehyde for fixation. All tissues were processed and stained with hematoxylin and eosin for histological evaluation. forceps to one side and a microsyringe was used to deposit 50 µl of inoculum onto the back of the tongue and proximal to the larynx. The inoculum was inhaled into the lungs by normal breathing. The mouse was then held in an upright position for 10 min and then allowed to recover (32) . The presence of clinical signs in mice was observed every hour during the first 12 hr and every 3 hr thereafter. Those animals that survived up to 24 h post inoculation were euthanized in a CO 2 chamber followed by cervical dislocation; mice judged to be moribund were euthanized immediately. This experimental protocol was approved by the Washington State University Institutional Animal Use and Care Committee. A full necropsy was performed immediately upon death and gross changes were recorded. Samples for bacteriology (lung, liver, spleen, and gastrointestinal tract) were immediately placed in sterile PBS. The histological samples were obtained from the same tissues as described above with lung and several sections of the small intestine insufflated and placed in 10% formaldehyde until they were processed.
Dose determination.
To establish a suitable dose for the wild-type strain (NY-4), 10 serial dilutions (10 4 to 10 10 ) of bacteria were inoculated into 28 adult C57BL/6 mice. The CFU/ml was calculated using the OD 600 measurement of overnight cultures and then verified through bacterial enumeration using a drop-plate technique (10) .
Mortality studies. The same methods for preparing inoculum were used for comparative studies and an estimated inoculum of 5×10 5 CFU was used in all cases. Four groups of 10 adult mice (C57BL/6) were infected with NY-4, T3SS1 KO, T3SS2 KO or T3SS1/2 KO. Two replicate studies were completed. Vehicle controls were used in one trial (n=5 mice) to confirm that our procedures did not confound the experimental outcome.
Bacteriology. All tissue samples were first weighed and then either stomached in 2 ml PBS (spleen and lung) or 10 ml PBS (liver and gastrointestinal tract). All samples were plated on TCBS and incubated at 37ºC overnight. When possible, bacterial CFU per gram of tissue was estimated.
Statistical analysis. ANOVA was used to compare culture growth and hemolytic activity and a P<0.05 was considered statistically significant. The clinical score was analyzed by ANOVA with repeated measures. Pair-wise comparisons were performed using Tukey-Kramer tests.
These analyses were conducted using NCSS 2004 (Number Cruncher Statistical system, Kaysville, UT). Analysis of the murine survival ratio was performed with the Kaplan-Maier and Log-Rank test using Graph Pad Prism 5.01 (GraphPad Software Inc, San Diego, CA).
RESULTS
Growth rates and hemolytic activity are equivalent for the strains employed in challenge experiments.
The growth rate and hemolytic activity of the wild-type and mutant strains used in this study were evaluated to determine if deletion mutations were compromised for these traits. There was no difference in the shape of the growth curves or the final OD 600 at 24 h (P>0.05; Fig. 1A ).
There were no differences between T3SSs mutants strains for hemolytic activity against HRBC (P>0.05; Fig. 1B ). We also included ΔexsA and ΔexsD strains in this analysis, which served as positive and negative regulators of the T3SS1 expression, respectively. Hemolytic activity was not different for either strain (Fig. 1B) . The inclusion of Δtdh-a deletion mutant confirmed that hemolysis in the hemolytic assay was responsive to the absence of TDH (P<0.0001) (Fig. 1B) .
From these data we concluded that results from our challenge experiments are not likely to be confounded by inadvertent differences in growth rates or by differences in TDH activity.
T3SS2 is required for gastrointestinal disease in two-day old piglets.
Two-day old piglets were inoculated with We observed no gross lesions related with V. parahaemolyticus infection in any of the piglets evaluated. At 8 h post infection piglets treated with NY-4 or T3SS1 KO had mildly distended jejunum and ileum with a moderate amount of yellow liquid digesta and gas. In addition, the cecum and spiral colon were filled with moderate to abundant amounts of soft pasty to liquid green digest. Histological examination showed that the cecal sub mucosa and serosa was moderately expanded by edema (Fig. 3) . No other histological changes were observed in all the tissues evaluated. Neither gross lesion nor histological changes were observed in piglets inoculated with T3SS2 KO and PBS.
Bacteria were consistently recovered at 8 h and 24 h post infection from the gastrointestinal tract of piglets infected with NY-4 or T3SS1 KO. Only one piglet infected with T3SS2 KO had recoverable bacteria from the gastrointestinal samples at 8 h post infection (Table   2 ). No V. parahaemolyticus was recovered in control animals or from the other tissue samples collected indicating that cross-contamination was not a confounding factor in these experiments.
Collectively, this data indicates that T3SS2 is required to cause gastrointestinal disease (acute diarrhea and vomiting) in neonatal pigs and deletion of the functional T3SS2 results in an absence of clinical symptoms characteristic of V. parahaemolyticus infection.
T3SS1 is necessary for mortality in intrapulmonary infected mice.
We initially determined that doses >10 6 CFU produced 100% mortality in the intrapulmonary mouse model, so we selected 5×10 5 CFU for these studies and this consistently produced 80-100% mortality using the wild-type NY-4 strain. To determine whether the presence of T3SS1 or T3SS2 is necessary for lethality in intrapulmonary model, mortality rates of mice infected with NY-4, T3SS1 KO, T3SS2 KO or T3SS1/2 KO were compared (Fig. 4) . distended by large aggregates of neutrophils, intermixed with some foamy macrophages, abundant edema and cellular debris. The interstitium was randomly infiltrated by small aggregates of neutrophils (Fig 5) . To better assess how V. parahaemolyticus strains were impacting mice at death, we repeated the challenge trial twice and collected bacterial counts where mice died or were euthanized between 8 and 12 h p.i. Importantly, when one mouse died or was moribund and euthanized, one mouse from each of the remaining treatments was simultaneously euthanized regardless of condition in order to obtain time-matched bacteriology data. No differences were observed in the counts of recovered bacteria from the lung, gastrointestinal tract or liver regardless of the strain used (Fig 6) . Mice inoculated with NY-4 and T3SS2 KO became bacteremic (70% and 30%, respectively) with similar blood CFU levels (0.7±0.6 and 0.4±0.1 Log 10 CFU±SD, respectively). From those bacteremic, spleen cultures were also positive in both NY-4 inoculated (45%) and T3SS2 KO inoculated (100%) animals. T3SS1
KO inoculated mice remained culture positive for V. parahaemolyticus in the lungs, gastrointestinal tract and liver after 24 , but only one animal's spleen was culture positive at this time. . This data indicates that T3SS1 is necessary to produce lethality following pulmonary challenge, and is also strongly associated with systemic V. parahaemolyticus infection.
DISCUSSION
In this study we developed two different animal models that are suitable to assess the differential contributions of T3SS1 (mouse) and T3SS2 (piglet) to V. parahaemolyticus virulence. We found no differences for in vitro growth rates between the strains used in this study so this is unlikely to be a confounding variable in the analysis. Similarly, we found no differences in beta-hemolytic activity between these strains indicating that deletion mutations were not affected for this important phenotype that is usually associated with thermostable direct hemolysin (TDH) (12) . TDH-dependent lysis in human red blood cells (HRBCs) is caused by formation of pores in the cell membrane and activation of cation channels (19). While T3SSs are involved in pore formation in the host-cell membrane and translocation of effector proteins directly into the target cells (9), there is no information regarding the contribution of these systems to hemolytic activity against HRBCs. Our results demonstrate that the soluble products from V. parahaemolyticus culture are sufficient to induce HRBC lysis, which is consistent with TDH activity, and the HRBC lysis phenotype is curtailed significantly when one of two tdh genes is deleted (tdh-a). Loss of function from either T3SS1 or T3SS2, however, made no impact on the in vitro HRBC hemolysis phenotype and thus differences between these strains in the animal challenges are not attributed to differences in TDH activity between strains.
Natural infection with V. parahaemolyticus causes acute gastrointestinal clinical signs, such as diarrhea, vomiting and abdominal cramping (28). An experimental rabbit ileal-loop model showed that V. parahaemolyticus infection results in fluid accumulation and this phenotype is associated with TDH production (5, 23). Nevertheless, it has also been shown that mutant strains lacking tdh-s and tdh-a genes are still able to cause intestinal fluid accumulation in the same model (26). There is also evidence indicating that T3SS2 is an important factor in fluid secretion for ileal loop models (17, 18, 27) . In the present study the clinical signs of infected piglets resembled the gastrointestinal presentation of the human disease. Challenge with the wild-type strain produced acute diarrhea with mild or moderate gross or histological lesions without bacteremia, and these signs and lesions required a functional T3SS2. Although T3SS2
has been previously associated with cell cytotoxicity in vitro and enterotoxicity in vivo (18), we found no signs of inflammation in the gastrointestinal tract nor were there any obvious morphological changes in the intestinal epithelium.
Our study was originally limited to deciphering the contribution of T3SS1 and T3SS2 to acute clinical symptoms and it is apparent that T3SS2 is involved. Nevertheless, because T3SS2
is encoded on an 80 kbp pathogenicity island and the genes encoding T3SS2 are flanked with tdh-a and tdh-s in the pandemic serovar (17) , it is possible that the mutation of a T3SS2 structural gene could have polar effects on the synthesis of TDH. This possibility is enhanced based on the fact that we have been unable to complement either our T3SS1 or T3SS2 deletion mutant strains probably owing to polar effects within the islands encoding the T3SSs.
Consequently, it is important to emphasize that we only detect a significant reduction in hemolytic activity when the tdh-a gene itself is deleted. The presence of a functional or dysfunctional T3SS2 had no effect on the apparent expression and functional activity of TDH and thus this is not a confounding variable in the analysis.
V. parahaemolyticus also causes wound infections, septicemia (from both the wound infections and, to a lesser extent, gastrointestinal infections) with immune-compromised patients being most at risk for possible mortality (14) . The pathogenic mechanisms involved in these clinical presentations are not clear. Previous studies have demonstrated that intraperitoneal infection in mice induces lethality that is not associated with the presence of TDH, implying that another pathogenic mechanism is involved (15) . Recently studies have demonstrated that T3SS1 is implicated in cellular oncosis and autophagy in vitro and this may be a major contributing factor to lethality in mice (13, 28, 33 ). Our results demonstrate that T3SS1 is necessary to cause lethality in intrapulmonary inoculated mice. The mortality rate and time course of the clinical signs agrees with those obtained by intraperitoneal infection in other studies (13, 15) . While T3SS1 has been described as causing cytotoxicity in various cell lines (25, 33), no histological difference were observed relative to either severity or distribution of pulmonary inflammatory response amongst the bacterial strains used in this study.
While the T3SS1 KO inoculated group showed the same inflammatory pattern of those inoculated with wild-type and T3SS2 KO and the bacterial recovery rate was the same between 8
and 12 h of infection, the high mortality rate requires a functional T3SS1. Moreover in those mice inoculated with T3SS1 KO the bacterial recovery rate after 24 h decreases dramatically (wild-type and T3SS2 KO treated mice rarely survived >12 hr). Consequently, when the T3SS1 is dysfunctional it is very likely that the host will clear the bacteria from the lung.
Interestingly, even when mice were infected with the T3SS1 KO strain, bacteria could be recovered from multiple organs and blood. Given that bacteremia occurs with the T3SS1 KO, bacteria were recovered in similar numbers from lung and there was no evidence of growth or TDH defects from this strain, it is likely that T3SS1-dependent mortality observed in this study is due to mechanisms that have been characterized in vitro, including autophagy (7) and oncosis (33) . It is also possible that an unrecognized T3SS1-dependent exotoxigenic factor is involved in lethality. Experiments that include a vopQ knockout (6) Δtdh-a ‡ NY-4 tdhA (vp1314) Thermostable direct hemolysin A This study ‡This deletion mutant was constructed using the methods of (25 ) but with the following primers: A1 (5'-ACGAATCGGAGCCAAAAT TCT-3'), A2 (5'-TACA TTAACAAAATACAATATCTCATCAGA-3'), A3 (5'-TCTGATGAGATATTGTATT TTGTTAATGTA-3'), A4 (5'-TGTAACCATCAGAAGCGAATA-3'). 
TABLES

